vs

Side-by-side financial comparison of Strategy Inc (MSTR) and MYRIAD GENETICS INC (MYGN). Click either name above to swap in a different company.

MYRIAD GENETICS INC is the larger business by last-quarter revenue ($209.8M vs $123.0M, roughly 1.7× Strategy Inc). On growth, Strategy Inc posted the faster year-over-year revenue change (1.9% vs -0.4%). Over the past eight quarters, Strategy Inc's revenue compounded faster (3.3% CAGR vs 1.9%).

Strategy Inc., formerly known as MicroStrategy, is an American company that provides business intelligence (BI) and mobile software. Founded in 1989 by Michael J. Saylor, Sanju Bansal, and Thomas Spahr, the firm develops software to analyze internal and external data in order to make business decisions and to develop mobile apps. It is a public company headquartered in Tysons Corner, Virginia, in the Washington metropolitan area. Its primary business analytics competitors include SAP SE Busin...

Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life, identify a pati...

MSTR vs MYGN — Head-to-Head

Bigger by revenue
MYGN
MYGN
1.7× larger
MYGN
$209.8M
$123.0M
MSTR
Growing faster (revenue YoY)
MSTR
MSTR
+2.3% gap
MSTR
1.9%
-0.4%
MYGN
Faster 2-yr revenue CAGR
MSTR
MSTR
Annualised
MSTR
3.3%
1.9%
MYGN

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
MSTR
MSTR
MYGN
MYGN
Revenue
$123.0M
$209.8M
Net Profit
Gross Margin
66.1%
70.0%
Operating Margin
-2.7%
Net Margin
Revenue YoY
1.9%
-0.4%
Net Profit YoY
EPS (diluted)
$-0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MSTR
MSTR
MYGN
MYGN
Q4 25
$123.0M
$209.8M
Q3 25
$128.7M
$205.7M
Q2 25
$114.5M
$213.1M
Q1 25
$111.1M
$195.9M
Q4 24
$120.7M
$210.6M
Q3 24
$116.1M
$213.3M
Q2 24
$111.4M
$211.5M
Q1 24
$115.2M
$202.2M
Net Profit
MSTR
MSTR
MYGN
MYGN
Q4 25
Q3 25
$2.8B
$-27.4M
Q2 25
$10.0B
$-330.5M
Q1 25
$-4.2B
$-100.0K
Q4 24
$-670.8M
Q3 24
$-340.2M
$-22.1M
Q2 24
$-102.6M
$-36.7M
Q1 24
$-53.1M
$-26.0M
Gross Margin
MSTR
MSTR
MYGN
MYGN
Q4 25
66.1%
70.0%
Q3 25
70.5%
69.9%
Q2 25
68.8%
71.2%
Q1 25
69.4%
68.5%
Q4 24
71.7%
71.7%
Q3 24
70.4%
70.2%
Q2 24
72.2%
69.6%
Q1 24
74.0%
68.1%
Operating Margin
MSTR
MSTR
MYGN
MYGN
Q4 25
-2.7%
Q3 25
-11.3%
Q2 25
-154.5%
Q1 25
-5331.4%
-14.8%
Q4 24
-842.1%
-18.6%
Q3 24
-372.7%
-9.4%
Q2 24
-179.7%
-17.3%
Q1 24
-176.8%
-13.8%
Net Margin
MSTR
MSTR
MYGN
MYGN
Q4 25
Q3 25
2164.1%
-13.3%
Q2 25
8752.7%
-155.1%
Q1 25
-3797.2%
-0.1%
Q4 24
-555.8%
Q3 24
-293.1%
-10.4%
Q2 24
-92.0%
-17.4%
Q1 24
-46.1%
-12.9%
EPS (diluted)
MSTR
MSTR
MYGN
MYGN
Q4 25
$-0.09
Q3 25
$8.42
$-0.29
Q2 25
$32.60
$-3.57
Q1 25
$-16.49
$0.00
Q4 24
$4.49
$-0.47
Q3 24
$-1.72
$-0.24
Q2 24
$-0.57
$-0.41
Q1 24
$-0.31
$-0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MSTR
MSTR
MYGN
MYGN
Cash + ST InvestmentsLiquidity on hand
$2.3B
$149.6M
Total DebtLower is stronger
$8.2B
$119.9M
Stockholders' EquityBook value
$44.1B
$368.0M
Total Assets
$61.6B
$706.6M
Debt / EquityLower = less leverage
0.19×
0.33×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MSTR
MSTR
MYGN
MYGN
Q4 25
$2.3B
$149.6M
Q3 25
$54.3M
$145.4M
Q2 25
$50.1M
$74.4M
Q1 25
$60.3M
$91.8M
Q4 24
$38.1M
$102.4M
Q3 24
$46.3M
$99.9M
Q2 24
$66.9M
$97.3M
Q1 24
$81.3M
$104.3M
Total Debt
MSTR
MSTR
MYGN
MYGN
Q4 25
$8.2B
$119.9M
Q3 25
$8.2B
$119.5M
Q2 25
$8.2B
Q1 25
$8.1B
Q4 24
$7.2B
Q3 24
$4.2B
Q2 24
$3.8B
Q1 24
$3.6B
Stockholders' Equity
MSTR
MSTR
MYGN
MYGN
Q4 25
$44.1B
$368.0M
Q3 25
$52.3B
$372.8M
Q2 25
$47.5B
$388.1M
Q1 25
$32.2B
$704.9M
Q4 24
$18.2B
$701.1M
Q3 24
$3.8B
$731.7M
Q2 24
$2.8B
$740.5M
Q1 24
$2.4B
$760.0M
Total Assets
MSTR
MSTR
MYGN
MYGN
Q4 25
$61.6B
$706.6M
Q3 25
$73.6B
$728.1M
Q2 25
$64.8B
$677.3M
Q1 25
$43.9B
$1.0B
Q4 24
$25.8B
$1.0B
Q3 24
$8.3B
$1.1B
Q2 24
$7.1B
$1.1B
Q1 24
$6.4B
$1.1B
Debt / Equity
MSTR
MSTR
MYGN
MYGN
Q4 25
0.19×
0.33×
Q3 25
0.16×
0.32×
Q2 25
0.17×
Q1 25
0.25×
Q4 24
0.39×
Q3 24
1.12×
Q2 24
1.36×
Q1 24
1.48×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MSTR
MSTR
MYGN
MYGN
Operating Cash FlowLast quarter
$10.6M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MSTR
MSTR
MYGN
MYGN
Q4 25
$10.6M
Q3 25
$-8.3M
$21.1M
Q2 25
$-34.9M
$-13.6M
Q1 25
$-2.4M
$-16.3M
Q4 24
$-17.3M
$6.6M
Q3 24
$-41.0M
$700.0K
Q2 24
$-23.3M
$2.6M
Q1 24
$28.6M
$-18.6M
Free Cash Flow
MSTR
MSTR
MYGN
MYGN
Q4 25
Q3 25
$-11.1M
Q2 25
$-37.0M
Q1 25
$-5.1M
Q4 24
$-17.6M
Q3 24
$-41.4M
Q2 24
$-24.1M
Q1 24
$27.0M
FCF Margin
MSTR
MSTR
MYGN
MYGN
Q4 25
Q3 25
-8.6%
Q2 25
-32.3%
Q1 25
-4.6%
Q4 24
-14.6%
Q3 24
-35.7%
Q2 24
-21.6%
Q1 24
23.5%
Capex Intensity
MSTR
MSTR
MYGN
MYGN
Q4 25
Q3 25
2.2%
Q2 25
1.8%
Q1 25
2.5%
Q4 24
0.2%
Q3 24
0.4%
Q2 24
0.6%
Q1 24
1.3%
Cash Conversion
MSTR
MSTR
MYGN
MYGN
Q4 25
Q3 25
-0.00×
Q2 25
-0.00×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons